Replies to post #5107 on Aurinia Pharmaceuticals Inc (AUPH)

[grandma_of_jbraika]

ILJIN KNOWS ABOUT ALL THE Voclosporin STORIES DEFINATELY BETTER THAN BR, humour412, socialidiocies and Flyingtrader. ILJIN has Dr. Hyuek Joon Lee on AUPH's board of directors. ILJIN has been being the absolutely #1 AUPH owner/investor since 2011. Why did ILJIN still acquire 20% or 5,185,185 shares of the 25,645,000 shares offered publicly on 03-13-2017? ILJIN knows AUPH shares are GOLD BAGS based on the phase 2 results updated in early 2017, doesn't it? ILJIN owns 17.35% of AUPH (14,205,457 shares) now. I don't think the faithful true longs' confidence on AUPH would be shaken by BR and humour412.

Quote: "ILJIN Life Science Co., Ltd. engages in the clinical and commercial development of voclosporin. The company is based in South Korea. ILJIN Life Science Co., Ltd. operates as a subsidiary of Iljin Holdings Co., Ltd. - https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=126747582

Dr. Hyuek Joon Lee is the Director of New Business Development for ILJIN Group and is responsible for mergers and acquisitions, and managing overseas investments, joint ventures and subsidiaries. As of October 2014 he joined the board of directors of Life Science Enterprises in Massachusetts, ..." Link: http://insiders.morningstar.com/trading/executive-profile.action?t=0P0000BLCT&PersonId=PS0000A8VP&flag=Director&insider=Hyuek_Lee&culture=en-CA&productcode=CAN&ops=clear&cur=

https://relationshipscience.com/hyuek-joon-lee-p157816980

This is Posted by ariadinvestor:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH

[grandma_of_jbraika]

"ILJIN's Hyuek Joon Lee is on AUPH's board of directors. ILJIN knows about any of the Voclosporin stories definitely better than BR, humour412, socialidiocies and Flyingtrader. ILJIN has been being the absolutely #1 AUPH owner/investor since 2011. Why did ILJIN still acquire 20+% or 5,185,185 shares of the 25,645,000 shares offered publicly on 03-13-2017? AUPH is good, isn't it? LJIN owns 17.35% of AUPH (14,205,457 shares) now after it added 5,185,185 shares at $6.75 in March. I don't think Katrina's confidence on AUPH would be shaken by BR and humour412."

https://relationshipscience.com/hyuek-joon-lee-p157816980

Dr. Hyuek Joon Lee is the Director of New Business Development for ILJIN Group and is responsible for mergers and acquisitions, and managing overseas investments, joint ventures and subsidiaries. As of October 2014 he joined the board of directors of Life Science Enterprises in Massachusetts, ..." Link: http://insiders.morningstar.com/trading/executive-profile.action?t=0P0000BLCT&PersonId=PS0000A8VP&flag=Director&insider=Hyuek_Lee&culture=en-CA&productcode=CAN&ops=clear&cur=



This is Posted by ariadinvestor:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH

[grandma_of_jbraika]

AUPH is run by a management team with deep experience in lupus nephritis (LN) and corporate development, having executed the ALMS study for CellCept and selling Aspreva and ZymoGenetics to large pharma companies ...

- https://www.docdroid.net/CIKaxJ9/aurinia-pharmaceuticals-inc-leerink1.pdf

Hotrodder/Foxxy says nobody my posts about AUPH. LOL!

[grandma_of_jbraika]

A double-blinded trial is used after initial trials show particular promise. Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.

A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com

http://www.medicinenet.com/script/main/art.asp?articlekey=11177

[grandma_of_jbraika]

Vidpok: "Duggan would be to Aurinia what Denner was to Ariad. Max value if he gets on the board."

Araidinvestor posted 3 months ago: ""Will Robert Duggan to Aurinia be Alex Denner to Ariad? I hope so. Robert Duggan Takes a 7.2% Stake in Aurinia (5,766,887 shares @6.50-8.85, AVG price 7.50?). This is great AUPH news to me."

https://finance.yahoo.com/quote/AUPH/community?p=AUPH

[grandma_of_jbraika]

I like your intuitions on
picking a good investment, AND your dogged stubborness in sticking
with your convictions. It's not a guarantee that it will work
out, BUT is sure did with Ariad, and I believe it will also
have similar results here (minus the drama there).

I cannot think of another biotech where the probability
for a favorable outcome is as good as AUPH. The people
running the show are top notch, have deep experience in
both the specific science (LN related issues), and the
business acumen based on a very similar (almost
the same) medical and business situation.

While it might take two years for approval, I think we'll
see upward movement before that, after all, Aurinia does
have other indications for Voc. and potential for deal-making.


Good luck to you and fellow longs,
zzaatt/amp

PS: This two year (blinded) wait seems pretty grotesque, given the
strong results in P2 and the fact that it will cost the lives
of thousands of very desperate patients. I always had a
profound contempt for the corrupt, hide-bound bureaucracy
known as the FDA and I'm hoping for big changes under Dr.Gottlieb!
Who knows, maybe some conditional approval may be possible,
it certainly should be, if the goal is to help sick people.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=133437830

[grandma_of_jbraika]

AUPH CEO Glickman says $4 billion market by 2022 ( http://bloombergtv.ca/2017-05-18/news/phase-iii-trials-underway-for-aurinia-pharmaceuticals-lupus-drug/ ). Motley Fool: "Sky's the limit - Peak U.S. Market Value = $6 billion assuming the low end of both patient population and pricing. EU patient population = 175,000 - 250,000. Aurinia looks to be significantly undervalued." - https://www.fool.com/investing/2017/03/31/aurinia-pharmaceuticals-where-to-from-here.aspx

This was posted by AI:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH

Advertise Here